Form 8-K Outlook Therapeutics, For: May 12

Go back to Form 8-K Outlook Therapeutics, For: May 12

Outlook Therapeutics enters $100 million at-the-market offering agreement

May 13, 2026 4:43 PM EDT

Outlook Therapeutics Inc. (NASDAQ: OTLK) entered into an at-the-market offering agreement with H.C. Wainwright & Co. LLC on May 13, 2026, allowing the company to sell up to $100 million worth of common stock shares.

Under the sales agreement, H.C. Wainwright will serve as sales agent... More